Keywordsobesity; nutrition assessment; fat utilization; Metabolic Syndrome; metabolically unhealthy Obesity; diabetes; obesity; metabolic syndrome; fatty acids; serum; youth; obesity; metabolically unhealthy obese; metabolically healthy obese; metabolic syndrome; non-alcoholic fatty liver disease; gut microbiota; Bacteroidetes; Firmicutes; endotoxemia; lipopolysaccharide; medium chain triglycerides; medium chain fatty acids; ghrelin; high salt; obesity; diet intervention; metabolic syndrome; obesity; metabolites; leptin receptor; polymorphisms; weight loss; adipokines; prepubertal period; metabolically healthy obesity; metabolic syndrome; adipose tissue; inflammation; obesity phenotype; metabolic abnormalities; HIV infection; mothers; serum leptin; BMI; breast milk; infancy; obesity; body mass index; mortality; hypertension; China; retroperitoneal adipose tissue; adipogenesis; stromal vascular fraction cells; cell determination; adipogenic competency; metabolically healthy; overweight and obese; weight change; metabolically healthy obesity; Lebanese dietary pattern; traditional dietary pattern; metabolically healthy obese; diet; biomarkers; eicosapentaenoic acid (EPA)/Docosahexaenoic acid (DHA); obesity; skeletal-muscle metabolism; mitochondrial β-oxidation; transcriptome
